Revealed: A Real Solution for Depression?

From Investing Trends | Ad

Depression is the leading cause of disability worldwide. For nearly 100 million people… there's no known solution. That's right. Nearly one-third of the world's 322 million people suffering from depression have no existing treatment. But that's all about to change.

Here's how you could capitalize off this

INO Insider Trading (Inovio Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,830,595.12

Inovio Pharmaceuticals Insider Trading History Chart

Inovio Pharmaceuticals Share Price & Price History

^$8.52

▼ -0.12 (-1.39%)

As of 06/22/2021 02:28 PM ET

Days: 30 | 90 | 365

Is this Seattle Penny Pot Stock a Potential Blockbuster?

From All Marijuana Stocks | Ad

A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.

Get Free Report on #1 Cannabis Pick for 2021

Inovio Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/9/2021	Jacqueline Elizabeth Shea	COO	Sell	38,535	$10.01	$385,735.35	21,592
6/9/2021	Laurent Humeau	Insider	Sell	10,318	$9.07	$93,584.26	78,904
6/9/2021	Peter Kies	CFO	Sell	33,750	$10.01	$337,837.50	164,538
6/3/2021	Peter Kies	CFO	Sell	10,000	$8.03	$80,300.00	150,788
5/17/2021	Lota S Zoth	Director	Sell	2,045	$6.62	$13,537.90	23,932
4/21/2021	David B. Weiner	Director	Sell	26,583	$8.57	$227,816.31	877,719
4/21/2021	Peter Kies	CFO	Sell	10,000	$8.52	$85,200.00	160,788
4/16/2021	Simon X Benito	Director	Sell	2,000	$8.75	$17,500.00	53,650
3/26/2021	Jacqueline Elizabeth Shea	COO	Sell	4,710	$8.97	$42,248.70	72,084
3/16/2021	Simon X Benito	Director	Sell	2,000	$10.41	$20,820.00
3/12/2021	Jacqueline Elizabeth Shea	COO	Sell	16,881	$10.06	$169,822.86	98,272
3/9/2021	David B Weiner	Director	Sell	7,000	$9.39	$65,730.00
2/3/2021	Jong Joseph Kim	CEO	Sell	62,500	$14.24	$890,000.00	1,078,313
2/1/2021	Jacqueline Elizabeth Shea	COO	Sell	28,336	$15.05	$426,456.80	66,871
2/1/2021	Jong Joseph Kim	CEO	Sell	100,000	$15.00	$1,500,000.00	1,078,313
1/28/2021	Jacqueline Elizabeth Shea	COO	Sell	16,713	$12.04	$201,224.52	34,296
1/15/2021	Peter Kies	CFO	Sell	30,000	$10.02	$300,600.00	149,290
12/15/2020	David B Weiner	Director	Sell	17,500	$10.71	$187,425.00	844,719
12/15/2020	Peter Kies	CFO	Sell	20,000	$10.69	$213,800.00	128,040
8/10/2020	Laurent Humeau	Insider	Sell	19,467	$19.06	$371,041.02	43,966
7/30/2020	Jong Joseph Kim	CEO	Sell	100,000	$21.13	$2,113,000.00	1,188,313
7/15/2020	Peter Kies	CFO	Sell	35,000	$24.95	$873,250.00	154,290
6/30/2020	Peter Kies	CFO	Sell	35,000	$26.50	$927,500.00	119,290
6/22/2020	Laurent Humeau	Insider	Sell	19,467	$14.70	$286,164.90	63,433
5/11/2020	David B Weiner	Director	Sell	2,404	$11.84	$28,463.36	827,219
3/12/2020	David B Weiner	Director	Sell	3,500	$11.14	$38,990.00	828,610
3/10/2020	David B Weiner	Director	Sell	3,500	$9.32	$32,620.00	828,610
1/13/2020	Jong Joseph Kim	CEO	Buy	22,500	$3.11	$69,975.00	1,100,707
8/30/2019	Laurent Humeau	Insider	Buy	4,500	$2.22	$9,990.00	50,333
8/1/2019	David B Weiner	Director	Sell	16,352	$2.72	$44,477.44	797,110
6/5/2019	Laurent Humeau	Insider	Buy	20,000	$2.50	$50,000.00	45,833
6/3/2019	Jong Joseph Kim	CEO	Sell	2,129,553	$2.36	$5,025,745.08	1,911,055
5/31/2019	Jong Joseph Kim	CEO	Sell	500,000	$2.44	$1,220,000.00	1,911,055
5/21/2019	Jong Joseph Kim	CEO	Sell	100,000	$3.31	$331,000.00	2,411,055
5/16/2019	Jong Joseph Kim	CEO	Sell	136,768	$3.50	$478,688.00	2,511,055
11/29/2018	Peter Kies	CFO	Sell	10,001	$5.28	$52,805.28	72,089
9/12/2018	Jong Joseph Kim	CEO	Sell	49,060	$5.37	$263,452.20	2,357,554
7/10/2018	Peter Kies	CFO	Sell	35,000	$4.44	$155,400.00	97,088

SEC Filings (Institutional Ownership Changes) for Inovio Pharmaceuticals (NASDAQ:INO)

35.18% of Inovio Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inovio Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/24/2021	Principal Financial Group Inc.	76,723	$0.71M	0.0%	+2.3%	0.037%
5/19/2021	Virtu Financial LLC	11,511	$0.11M	0.0%	-86.3%	0.005%
5/18/2021	Verition Fund Management LLC	10,060	$93K	0.0%	N/A	0.005%
5/18/2021	State of Wisconsin Investment Board	249,300	$2.31M	0.0%	+13.4%	0.119%
5/18/2021	Morgan Stanley	290,591	$2.70M	0.0%	-49.6%	0.139%
5/18/2021	Cubist Systematic Strategies LLC	29,316	$0.27M	0.0%	+260.5%	0.014%
5/18/2021	California State Teachers Retirement System	279,359	$2.59M	0.0%	+16.5%	0.133%
5/17/2021	Great West Life Assurance Co. Can	11,824	$0.11M	0.0%	+23.5%	0.006%
5/17/2021	AQR Capital Management LLC	36,354	$0.34M	0.0%	-56.6%	0.017%
5/17/2021	Royal Bank of Canada	47,746	$0.44M	0.0%	+92.8%	0.023%
5/17/2021	Credit Agricole S A	13,000	$0.12M	0.0%	+225.0%	0.006%
5/17/2021	Price T Rowe Associates Inc. MD	145,815	$1.35M	0.0%	-7.1%	0.070%
5/17/2021	Ameriprise Financial Inc.	10,707	$99K	0.0%	N/A	0.005%
5/17/2021	Quantitative Investment Management LLC	51,629	$0.48M	0.0%	N/A	0.025%
5/17/2021	Nuveen Asset Management LLC	1,765,672	$16.39M	0.0%	+33.3%	0.843%
5/17/2021	Centiva Capital LP	20,497	$0.19M	0.0%	+73.6%	0.010%
5/17/2021	Goldman Sachs Group Inc.	254,941	$2.37M	0.0%	+37.0%	0.122%
5/14/2021	Coatue Management LLC	3,126,923	$29.02M	0.2%	-12.6%	1.493%
5/14/2021	Eqis Capital Management Inc.	21,746	$0.20M	0.0%	N/A	0.010%
5/14/2021	Public Employees Retirement System of Ohio	84,437	$0.78M	0.0%	-7.9%	0.040%
5/14/2021	UBS Asset Management Americas Inc.	174,512	$1.62M	0.0%	-10.1%	0.083%
5/14/2021	Stifel Financial Corp	61,171	$0.57M	0.0%	+11.1%	0.029%
5/13/2021	Guggenheim Capital LLC	147,950	$1.37M	0.0%	-4.0%	0.071%
5/13/2021	Trexquant Investment LP	72,714	$0.68M	0.1%	N/A	0.035%
5/13/2021	SG Americas Securities LLC	36,482	$0.34M	0.0%	-5.9%	0.017%
5/13/2021	Barclays PLC	156,026	$1.45M	0.0%	-19.2%	0.075%
5/13/2021	Bank of New York Mellon Corp	715,772	$6.64M	0.0%	+10.9%	0.344%
5/13/2021	Citigroup Inc.	501,857	$4.66M	0.0%	+277.7%	0.241%
5/12/2021	Northern Trust Corp	2,117,295	$19.65M	0.0%	+11.2%	1.016%
5/12/2021	Geode Capital Management LLC	3,320,869	$30.82M	0.0%	+31.6%	1.594%
5/12/2021	Moors & Cabot Inc.	13,700	$0.13M	0.0%	N/A	0.007%
5/12/2021	Prudential Financial Inc.	14,150	$0.13M	0.0%	+12.7%	0.007%
5/12/2021	JPMorgan Chase & Co.	1,579,573	$14.66M	0.0%	+44.0%	0.758%
5/12/2021	E Fund Management Co. Ltd.	13,205	$0.12M	0.0%	N/A	0.006%
5/12/2021	UBS Group AG	108,041	$1M	0.0%	+88.5%	0.052%
5/11/2021	Teacher Retirement System of Texas	23,704	$0.22M	0.0%	+67.5%	0.011%
5/11/2021	New York State Common Retirement Fund	153,100	$1.42M	0.0%	+7.9%	0.073%
5/11/2021	Vontobel Holding Ltd.	117,803	$1.09M	0.0%	-4.9%	0.057%
5/11/2021	Keystone Financial Group	56,255	$0.52M	0.1%	+44.0%	0.027%
5/10/2021	Russell Investments Group Ltd.	30,461	$0.28M	0.0%	+37.9%	0.015%
5/10/2021	Wasatch Advisors Inc.	3,191,675	$29.62M	0.1%	-19.0%	1.532%
5/10/2021	Kestra Advisory Services LLC	13,280	$0.12M	0.0%	N/A	0.006%
5/10/2021	State Board of Administration of Florida Retirement System	62,443	$0.58M	0.0%	-4.5%	0.030%
5/10/2021	Principal Financial Group Inc.	76,723	$0.71M	0.0%	+2.3%	0.037%
5/10/2021	Rafferty Asset Management LLC	691,280	$6.42M	0.0%	+399.9%	0.332%
5/10/2021	Shell Asset Management Co.	11,421	$0.11M	0.0%	-15.6%	0.005%
5/10/2021	GSA Capital Partners LLP	24,566	$0.23M	0.0%	+30.0%	0.012%
5/7/2021	BlackRock Inc.	17,515,053	$162.54M	0.0%	+23.0%	8.408%
5/7/2021	American International Group Inc.	107,944	$1M	0.0%	+17.1%	0.052%
5/7/2021	Cambridge Investment Research Advisors Inc.	97,141	$0.90M	0.0%	+19.3%	0.047%
5/7/2021	BNP Paribas Arbitrage SA	22,982	$0.21M	0.0%	-60.2%	0.011%
5/7/2021	Alps Advisors Inc.	375,655	$3.49M	0.0%	+24.1%	0.180%
5/7/2021	Sowell Financial Services LLC	4,524	$29K	0.0%	+4,424.0%	0.002%
5/7/2021	Valley National Advisers Inc.	11,700	$0.11M	0.0%	-25.5%	0.006%
5/7/2021	Swiss National Bank	472,400	$4.38M	0.0%	+24.7%	0.227%
5/6/2021	Arizona State Retirement System	60,185	$0.56M	0.0%	+23.9%	0.029%
5/6/2021	Rhumbline Advisers	222,610	$2.07M	0.0%	+8.4%	0.107%
5/6/2021	Harvest Investment Services LLC	53,506	$0.50M	0.2%	-13.5%	0.026%
5/6/2021	Alliancebernstein L.P.	218,900	$2.03M	0.0%	+2.0%	0.105%
5/6/2021	Greenwich Wealth Management LLC	23,351	$0.22M	0.0%	+93.8%	0.011%
5/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	32,073	$0.30M	0.0%	+46.3%	0.015%
5/5/2021	EMC Capital Management	26,959	$0.25M	0.2%	+78.2%	0.013%
5/4/2021	Commonwealth Equity Services LLC	38,195	$0.35M	0.0%	-5.4%	0.018%
5/4/2021	Migdal Insurance & Financial Holdings Ltd.	54,164	$0.50M	0.0%	+163.6%	0.026%
5/4/2021	Victory Capital Management Inc.	31,709	$0.29M	0.0%	-19.8%	0.015%
5/3/2021	The Manufacturers Life Insurance Company	103,642	$0.96M	0.0%	+9.1%	0.050%
4/28/2021	US Bancorp DE	8,576	$80K	0.0%	+21.9%	0.004%
4/27/2021	Stratos Wealth Partners LTD.	20,284	$0.19M	0.0%	+37.1%	0.010%
4/27/2021	State of New Jersey Common Pension Fund D	185,140	$1.72M	0.0%	-1.7%	0.089%
4/23/2021	Mayflower Financial Advisors LLC	30,402	$0.28M	0.0%	+4.6%	0.015%
4/22/2021	Private Advisor Group LLC	11,555	$0.11M	0.0%	-17.9%	0.006%
4/20/2021	Defender Capital LLC.	130,466	$1.21M	0.4%	+31.1%	0.063%
4/19/2021	International Assets Investment Management LLC	24,064	$0.22M	0.0%	+121.6%	0.012%
4/13/2021	HBW Advisory Services LLC	10,098	$94K	0.0%	N/A	0.005%
4/13/2021	Golden Green Inc.	36,623	$0.34M	0.3%	+235.4%	0.018%
4/5/2021	Pacer Advisors Inc.	7,423	$69K	0.0%	-38.0%	0.004%
3/12/2021	DekaBank Deutsche Girozentrale	54,000	$0.48M	0.0%	-4.4%	0.026%
3/9/2021	Amundi Pioneer Asset Management Inc.	65,037	$0.58M	0.0%	+325.1%	0.031%
3/2/2021	Norges Bank	1,517,269	$13.43M	0.0%	N/A	0.812%
3/1/2021	UBS Asset Management Americas Inc.	194,020	$1.72M	0.0%	+1.6%	0.104%
2/25/2021	Hsbc Holdings PLC	56,550	$0.50M	0.0%	+300.2%	0.030%
2/24/2021	Virtu Financial LLC	84,012	$0.74M	0.1%	+24.1%	0.045%
2/24/2021	EMC Capital Management	15,128	$0.13M	0.1%	N/A	0.008%
2/24/2021	Bank Julius Baer & Co. Ltd Zurich	4,972	$44K	0.0%	-87.9%	0.003%
2/23/2021	Principal Financial Group Inc.	75,029	$0.66M	0.0%	+68.7%	0.040%
2/23/2021	UBP Investment Advisors SA	15,000	$0.13M	0.1%	N/A	0.008%
2/19/2021	JPMorgan Chase & Co.	1,096,649	$9.71M	0.0%	+108.3%	0.587%
2/18/2021	Safeguard Investment Advisory Group LLC	3,000	$26K	0.0%	N/A	0.002%
2/18/2021	Truist Financial Corp	15,040	$0.13M	0.0%	N/A	0.008%
2/16/2021	Squarepoint Ops LLC	82,916	$0.73M	0.0%	+189.9%	0.044%
2/16/2021	Morgan Stanley	577,082	$5.11M	0.0%	-10.2%	0.309%
2/16/2021	Nuveen Asset Management LLC	1,362,421	$12.06M	0.0%	+41.0%	0.729%
2/16/2021	Guggenheim Capital LLC	154,113	$1.36M	0.0%	+16.6%	0.082%
2/16/2021	Price T Rowe Associates Inc. MD	156,984	$1.39M	0.0%	+85.4%	0.084%
2/16/2021	Amundi Pioneer Asset Management Inc.	65,037	$0.58M	0.0%	+325.1%	0.035%
2/16/2021	ETF Managers Group LLC	82,399	$0.74M	0.0%	-23.0%	0.044%
2/16/2021	ExodusPoint Capital Management LP	30,252	$0.27M	0.0%	N/A	0.016%
2/16/2021	Charles Schwab Investment Management Inc.	1,095,477	$9.70M	0.0%	+1.8%	0.586%
2/13/2021	Essex Investment Management Co. LLC	59,533	$0.53M	0.1%	N/A	0.032%
2/13/2021	American International Group Inc.	92,167	$0.82M	0.0%	-1.7%	0.049%

Data available starting January 2016

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Today's Range

Now: $8.52

$8.40

$8.72

50 Day Range

MA: $7.72

$6.23

$10.03

52 Week Range

Now: $8.52

$5.81

$33.79

Volume

45,096 shs

Average Volume

11,848,646 shs

Market Capitalization

$1.78 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66

Who are the company insiders with the largest holdings of Inovio Pharmaceuticals?

Inovio Pharmaceuticals' top insider shareholders include:

Jong Joseph Kim (CEO)
David B Weiner (Director)
David B Weiner (Director)
Peter Kies (CFO)
Jacqueline Elizabeth Shea (COO)
Laurent Humeau (Insider)
Simon X Benito (Director)
Lota S Zoth (Director)

Who are the major institutional investors of Inovio Pharmaceuticals?

Inovio Pharmaceuticals' top institutional shareholders include:

BlackRock Inc. — 8.41%
Geode Capital Management LLC — 1.59%
Wasatch Advisors Inc. — 1.53%
Coatue Management LLC — 1.49%
Northern Trust Corp — 1.02%
Nuveen Asset Management LLC — 0.84%

Which institutional investors are selling Inovio Pharmaceuticals stock?

Within the previous quarter, INO stock was sold by these institutional investors:

Wasatch Advisors Inc.
Coatue Management LLC
Morgan Stanley
Virtu Financial LLC
AQR Capital Management LLC
Barclays PLC
BNP Paribas Arbitrage SA
UBS Asset Management Americas Inc.

In the previous year, company insiders that have sold Inovio Pharmaceuticals company stock include:

Jong Joseph Kim (CEO)
David B Weiner (Director)
David B Weiner (Director)
Peter Kies (CFO)
Jacqueline Elizabeth Shea (COO)
Laurent Humeau (Insider)
Simon X Benito (Director)
Lota S Zoth (Director)

Which institutional investors are buying Inovio Pharmaceuticals stock?

Within the previous quarter, INO stock was purchased by institutional investors including:

BlackRock Inc.
Geode Capital Management LLC
Rafferty Asset Management LLC
JPMorgan Chase & Co.
Nuveen Asset Management LLC
Citigroup Inc.
Northern Trust Corp
Swiss National Bank

During the previous year, these company insiders have bought Inovio Pharmaceuticals stock:

Jong Joseph Kim (CEO)
David B Weiner (Director)

Revealed: A Real Solution for Depression?

From Investing Trends | Ad

Here's how you could capitalize off this